V-RULES: Real-World Effectiveness and Safety of CPX-351 for First-Line Treatment of Therapy-Related Acute Myeloid Leukemia (AML) or AML with Myelodysplasia-Related Changes in the US
V-RULES: Real-World Effectiveness and Safety of CPX-351 for First-Line Treatment of Therapy-Related Acute Myeloid Leukemia (AML) or AML with Myelodysplasia-Related Changes in the US. // Clinical Lymphoma, Myeloma & Leukemia. – URL: https://www.sciencedirect.com/science/article/pii/S2152265026040401?dgcid=rss_sd_all
V-RULES: Real-World Effectiveness and Safety of CPX-351 for First-Line Treatment of Therapy-Related Acute Myeloid Leukemia (AML) or AML with Myelodysplasia-Related Changes in the US. Clinical Lymphoma, Myeloma & Leukemia. https://www.sciencedirect.com/science/article/pii/S2152265026040401?dgcid=rss_sd_all
“V-RULES: Real-World Effectiveness and Safety of CPX-351 for First-Line Treatment of Therapy-Related Acute Myeloid Leukemia (AML) or AML with Myelodysplasia-Related Changes in the US.” Clinical Lymphoma, Myeloma & Leukemia.
@article{article99929,
title = {V-RULES: Real-World Effectiveness and Safety of CPX-351 for First-Line Treatment of Therapy-Related Acute Myeloid Leukemia (AML) or AML with Myelodysplasia-Related Changes in the US},
journal = {Clinical Lymphoma, Myeloma \& Leukemia},
url = {https://www.sciencedirect.com/science/article/pii/S2152265026040401?dgcid=rss_sd_all}
}